NOTES
2. Segment information
| Q1 2026 | Q1 2025 | |||||||
|---|---|---|---|---|---|---|---|---|
| EUR million | Healthcare Services | Diagnostic Services | Central/other | Group Total | Healthcare Services | Diagnostic Services | Central/other | Group Total |
| Revenue | 431.7 | 200.3 | 0.4 | 402.6 | 182.2 | 0.1 | ||
| Inter-segment revenue | -0.7 | -7.2 | -0.3 | -0.5 | -6.3 | 0.0 | ||
| Revenue from external customers | 431.0 | 193.1 | 0.1 | 624.2 | 402.1 | 175.9 | 0.1 | 578.1 |
| By payer: | ||||||||
| Private | 359.9 | 137.7 | 0.1 | 497.7 | 332.7 | 120.8 | 0.1 | 453.6 |
| Public | 71.1 | 55.4 | 0.0 | 126.5 | 69.4 | 55.1 | 0.0 | 124.5 |
| By country: | ||||||||
| Poland | 309.3 | 22.2 | 0.0 | 331.5 | 275.2 | 22.1 | 0.1 | 297.4 |
| Germany | 12.2 | 85.0 | - | 97.2 | 15.1 | 83.2 | - | 98.3 |
| Romania | 49.5 | 36.1 | - | 85.6 | 45.1 | 31.4 | - | 76.5 |
| India | 54.3 | - | 0.0 | 54.3 | 47.5 | - | 0.0 | 47.5 |
| Ukraine | 2.0 | 21.8 | - | 23.8 | 2.4 | 21.0 | - | 23.4 |
| Other countries | 3.7 | 28.0 | 0.1 | 31.8 | 16.8 | 18.2 | 0.0 | 35.0 |
| Operating profit | 35.6 | 26.8 | -15.7 | 46.7 | 27.0 | 22.0 | -13.0 | 36.0 |
| Margin | 8.2% | 13.4% | 7.5% | 6.7% | 12.1% | 6.2% | ||
| Depreciation, amortisation and impairment | 38.7 | 14.9 | 0.9 | 54.5 | 35.9 | 13.9 | 0.7 | 50.5 |
| EBITDA | 74.3 | 41.7 | -14.8 | 101.2 | 62.9 | 35.9 | -12.3 | 86.5 |
| Margin | 17.2% | 20.8% | 16.2% | 15.6% | 19.7% | 15.0% | ||
| Right-of-use depreciation/impairment | -18.1 | -6.9 | -0.1 | -25.1 | -16.4 | -6.0 | -0.1 | -22.5 |
| Interest on lease liabilities | -7.3 | -1.4 | 0.0 | -8.7 | -6.5 | -1.2 | 0.0 | -7.7 |
| Segment result: EBITDAaL | 48.9 | 33.4 | -14.9 | 67.4 | 40.0 | 28.7 | -12.4 | 56.3 |
| Margin | 11.3% | 16.7% | 10.8% | 9.9% | 15.7% | 9.7% | ||
| Other income/(costs) | 0.0 | 0.2 | ||||||
| Net interest expense | -15.6 | -14.2 | ||||||
| Other financial income/(expense) | -2.5 | 4.1 | ||||||
| Share of profit of associates | 0.0 | 0.0 | ||||||
| Income tax | -8.0 | -7.3 | ||||||
| Profit for period | 20.6 | 18.8 | ||||||
| LTM | FY 2025 | |||||||
|---|---|---|---|---|---|---|---|---|
| EUR million | Healthcare Services | Diagnostic Services | Central/other | Group Total | Healthcare Services | Diagnostic Services | Central/other | Group Total |
| Revenue | 1,679.3 | 773.0 | 1.0 | 1,650.2 | 754.9 | 0.7 | ||
| Inter-segment revenue | -2.3 | -26.1 | -0.7 | -2.1 | -25.2 | -0.4 | ||
| Revenue from external customers | 1,677.0 | 746.9 | 0.3 | 2,424.2 | 1,648.1 | 729.7 | 0.3 | 2,378.1 |
| By payer: | ||||||||
| Private | 1,394.0 | 524.2 | 0.3 | 1,918.5 | 1,366.8 | 507.3 | 0.3 | 1,874.4 |
| Public | 283.0 | 222.7 | 0.0 | 505.7 | 281.3 | 222.4 | 0.0 | 503.7 |
| By country: | ||||||||
| Poland | 1,187.1 | 87.3 | 0.0 | 1,274.4 | 1,153.0 | 87.2 | 0.1 | 1,240.3 |
| Germany | 54.2 | 326.7 | - | 380.9 | 57.1 | 324.9 | - | 382.0 |
| Romania | 190.4 | 138.3 | - | 328.7 | 186.0 | 133.6 | - | 319.6 |
| India | 210.3 | - | 0.1 | 210.4 | 203.5 | - | 0.1 | 203.6 |
| Ukraine | 8.4 | 86.1 | - | 94.5 | 8.8 | 85.3 | - | 94.1 |
| Other countries | 26.6 | 108.5 | 0.2 | 135.3 | 39.7 | 98.7 | 0.1 | 138.5 |
| Operating profit | 143.1 | 84.3 | -61.0 | 166.4 | 134.5 | 79.5 | -58.3 | 155.7 |
| Margin | 8.5% | 10.9% | 6.9% | 8.1% | 10.5% | 6.5% | ||
| Depreciation, amortisation and impairment | 155.9 | 60.0 | 3.4 | 219.3 | 153.1 | 59.0 | 3.2 | 215.3 |
| EBITDA | 299.0 | 144.3 | -57.6 | 385.7 | 287.6 | 138.5 | -55.1 | 371.0 |
| Margin | 17.8% | 18.7% | 15.9% | 17.4% | 18.3% | 15.6% | ||
| Right-of-use depreciation/impairment | -70.9 | -27.4 | -0.3 | -98.6 | -69.2 | -26.5 | -0.3 | -96.0 |
| Interest on lease liabilities | -27.5 | -5.4 | 0.0 | -32.9 | -26.7 | -5.2 | 0.0 | -31.9 |
| Segment result: EBITDAaL | 200.6 | 111.5 | -57.9 | 254.2 | 191.7 | 106.8 | -55.4 | 243.1 |
| Margin | 11.9% | 14.4% | 10.5% | 11.6% | 14.1% | 10.2% | ||
| Other income/(costs) | 1.4 | 1.6 | ||||||
| Net interest expense | -61.1 | -59.7 | ||||||
| Other financial income/(expense) | -5.9 | 0.7 | ||||||
| Share of profit of associates | 0.1 | 0.1 | ||||||
| Income tax | -26.4 | -25.7 | ||||||
| Profit for period | 74.5 | 72.7 | ||||||